Sialyl-Lewis x Cer (d20:1/24:1) is a glycosphingolipid subtype, which can be used as an effective standard in the research of the migration mechanism of cancer.
CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.